BRF2 and breast carcinoma: Similarly, in breast cancer lines, MDA-MB-231 and SUM159PT, using a longer time course of up to 24 h, we observed a similar rapid and persistent upregulation of BRF2 upon DNA damage (Figure 2D,E).